SCHEMBL6769818

SCHEMBL6769818

COc1cccc(OC)c1-c1nn(-c2ccc(C(C)C)cc2)c2c1C(=O)C(C#N)C(C)(C)C2

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.34
P2RX3 P56373 2/20 0.34
NPBWR1 P48145 2/20 0.33
MCHR1 Q99705 2/20 0.33
IDH1 O75874 2/20 0.33
ESRRA P11474 1/20 0.32
MDM4 O15151 3/20 0.32
MDM2 Q00987 3/20 0.32
FAAH O00519 1/20 0.31
MEN1 O00255 1/20 0.31
LMNA P02545 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
HTT P42858 1/20 0.31
KMT2A Q03164 1/20 0.31
HTR2C P28335 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC8 Q9BY41 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6777360 0.87 OPRM1 (0.39) OPRM1NPBWR1MCHR1FAAHMEN1
SCHEMBL6771336 0.86 CCNA2 (0.37) OPRM1P2RX3NPBWR1MCHR1IDH1
SCHEMBL6770531 0.86 MEN1 (0.40) OPRM1MEN1LMNACYP1A2CYP3A4
SCHEMBL6771211 0.83 MEN1 (0.34) OPRM1MEN1LMNACYP1A2CYP3A4
SCHEMBL6770141 0.83 PTGS1 (0.41) OPRM1NPBWR1MCHR1MEN1LMNA
SCHEMBL6766535 0.82 DHODH (0.36) OPRM1ESRRAMEN1LMNACYP1A2
SCHEMBL6767179 0.82 POLB (0.35) OPRM1MEN1LMNACYP1A2CYP3A4
SCHEMBL6771166 0.81 OPRM1 (0.32) OPRM1NPBWR1MCHR1MEN1LMNA
SCHEMBL6770382 0.81 MEN1 (0.34) OPRM1NPBWR1MCHR1MEN1LMNA
SCHEMBL6165463 0.77 RAB9A (0.41) P2RX3MEN1LMNAHTTKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed